• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Generali CEO wins board backing amid shareholder row

September 27, 2021 by David Barret Leave a Comment

September 27, 2021

By Gianluca Semeraro and Claudia Cristoferi

MILAN (Reuters) -The board of Assicurazioni Generali on Monday threw its weight behind the reappointment of Chief Executive Philippe Donnet, overlooking opposition from two leading shareholders in Italy’s top insurer, two people close to the matter said.

Donnet’s fate had been called into question by a boardroom row at Generali, Europe’s third-largest insurer and one of Italy’s most prized financial assets, just as the French manager prepared to present a new business plan in December.

The two sources said Generali’s outgoing board had agreed by a majority vote to file a slate of nominees for shareholders to vote upon in the spring, including Donnet as CEO.

The decision was backed by nine of 13 members of the board, one of the sources said.

The source said the board would set up a dedicated committee to put together the list, with support from headhunters and legal advisers as well as oversight from Generali Chairman Gabriele Galateri.

Donnet’s reappointment meets resistance from influential Italian businessmen Francesco Gaetano Caltagirone, 78, and Leonardo Del Vecchio, 86.

The two tycoons, respectively Generali’s second and third largest investors, have criticised Donnet’s merger and acquisition strategy as too timid.

On the contrary, top investor Mediobanca backs a third mandate for Donnet, who has steered Generali through the COVID-19 crisis, keeping it on track to meet targets to the end of 2021.

Del Vecchio, founder of Ray-Ban owner Luxottica, and Caltagirone, a construction magnate, have been steadily lifting their Generali stakes, while also building holdings in Mediobanca, piling pressure on its boss Alberto Nagel.

Earlier this month Del Vecchio and Caltagirone announced an accord to consult over decisions concerning Generali, where they control a combined 12.5% stake after a third smaller investor recently joined their pact.

That threshold is not far from Mediobanca’s 13% stake in Generali, which makes the insurer a major contributor to the profit of the Milanese investment bank, which last week borrowed more shares in Generali to reach 17.2% of the Trieste-based insurer’s voting rights.

Del Vecchio, who two years ago rocked Italy’s financial establishment by emerging as the biggest investor in Mediobanca, has criticised its reliance on the Generali stake.

Mediobanca has said it would keep the beefed-up voting stake in Generali until next spring’s AGM, where shareholders will have the last word on the choice of CEO.

Institutional investors, which account for around 40% of Generali’s shareholder base, will play a key role.

Del Vecchio and Caltagirone are ready to back an alternative list of nominees for the board’s renewal, people with knowledge of the matter have previously told Reuters.

(Reporting by Gianluca Semeraro and Claudia Cristoferi; writing by Valentina Za; editing by Alexander Smith and Angus MacSwan)

Source Link Generali CEO wins board backing amid shareholder row

David Barret
David Barret

Related posts:

  1. Watch Apple unveil the new iPhone live right here
  2. Ghanaian featherweight aims to go pro after historic Olympic bronze
  3. U.S. core consumer prices slow sharply in August
  4. LinkedIn is launching its own $25M fund and incubator for creators

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • First Visible Time Crystals Ever Made Have Astonishing Complexity And Practical Potential
  • “Something Undeniably Special”: The Chi Cygnids, A New Five-Yearly Meteor Shower, Peak This Month
  • A 200-Meter-Tall Event We Didn’t See Sent Signals Through The Earth For Nine Whole Days
  • Why Are So Many Volcanoes Underwater?
  • In 1977, A Hybrid Was Born In A Zoo. What It Taught Us Could Save One Of The Planet’s Most Endangered Species
  • How To Park A Dangerous Asteroid So It Doesn’t Bite You Later
  • New Study Finds Evidence For What Every Parent Knows About Bluey
  • New Breakthrough Takes Plastic Garbage And Turns It Into Tool For Carbon Capture
  • NASA To Hold Press Conference About New Perseverance Rover Discovery Tomorrow
  • Strange Halos Have Formed Around Barrels Of Chemicals Dumped Off LA’s Coast Over 50 Years Ago
  • As We Grow Older, Our Music Taste Appears To Narrow To Fewer Songs
  • Stinky Seaweed Blob On Florida Beaches Thwarts Baby Sea Turtles’ Dash To The Ocean
  • NASA Is Set To Lock Up Four Volunteers For 378-Day Mars Simulation Study
  • For The First Time, A Vital Oceanic Upwelling Of Nutrient-Rich Water Failed To Emerge In 2025
  • One Of The Largest Crocs Ever “Terrorized Dinosaurs” With Teeth The Size Of Bananas
  • US Congress Is Holding Another UFO Hearing Today – Watch Live
  • Yes, Flying Snakes Do Exist – Sort Of
  • Meet The Bumblebee Bat: The World’s Smallest Bat Is The Last Of Its Kind
  • Did A Giant Planet Sculpt Fomalhaut’s Stunning Ring Into Its Squashed Shape?
  • The Unfolding New Astronomical Revolution – Gravitational Waves Discovery Turns 10
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version